- Tytuł:
- BioMarin Gene Therapy For Hemophilia Scores In Trial; Stock Jumps.
- Autorzy:
- Temat:
-
BIOMARINE Inc.
HEMOPHILIA
STOCKS (Finance)X chromosome abnormalities
ECONOMIC competition
GENE therapy - Źródło:
- Investors Business Daily. 4/20/2016, p1. 1p.
Wiadomości